St. Louis Financial Planners Asset Management LLC Buys New Holdings in Astera Labs, Inc. $ALAB

St. Louis Financial Planners Asset Management LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 2,704 shares of the company’s stock, valued at approximately $963,000.

Other hedge funds have also added to or reduced their stakes in the company. Mosley Wealth Management raised its holdings in Astera Labs by 12.7% during the 3rd quarter. Mosley Wealth Management now owns 497 shares of the company’s stock worth $177,000 after buying an additional 56 shares during the period. Howard Capital Management LLC bought a new position in Astera Labs in the third quarter valued at approximately $1,112,000. NFSG Corp lifted its stake in Astera Labs by 83.0% in the third quarter. NFSG Corp now owns 10,623 shares of the company’s stock valued at $3,781,000 after buying an additional 4,818 shares in the last quarter. Assenagon Asset Management S.A. boosted its holdings in shares of Astera Labs by 886.9% in the third quarter. Assenagon Asset Management S.A. now owns 74,746 shares of the company’s stock valued at $26,607,000 after buying an additional 67,172 shares during the period. Finally, State of Alaska Department of Revenue boosted its holdings in shares of Astera Labs by 6.4% in the third quarter. State of Alaska Department of Revenue now owns 2,507 shares of the company’s stock valued at $892,000 after buying an additional 150 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Trading Down 5.4%

Shares of Astera Labs stock traded down $16.16 during trading on Friday, hitting $285.82. 4,159,250 shares of the stock were exchanged, compared to its average volume of 4,402,957. The stock has a market capitalization of $49.59 billion, a price-to-earnings ratio of 141.50 and a beta of 3.68. The company has a fifty day moving average price of $314.86 and a 200-day moving average price of $297.01. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The company’s quarterly revenue was up 104.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts forecast that Astera Labs, Inc. will post 2.70 EPS for the current fiscal year.

Insider Activity at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the sale, the director owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the business’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.50, for a total value of $2,315,740.50. Following the transaction, the general counsel directly owned 96,542 shares of the company’s stock, valued at approximately $32,872,551. The trade was a 6.58% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders sold 408,558 shares of company stock valued at $127,306,034. 10.40% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research firms recently commented on ALAB. Barclays boosted their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Susquehanna increased their target price on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a report on Friday, July 31st. Morgan Stanley lifted their price target on Astera Labs to $335.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Northland Securities downgraded Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Friday, October 9th. Finally, Jefferies Financial Group boosted their price target on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Eleven research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $348.33.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.